Clinical benefits of trimetazidine in patients with recurrent angina

Coronary Artery Disease

Volumn 15, Issue SUPPL. 1, 2004, Pages

  Szwed, Hanna ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Coronary artery disease; Metabolic agent; Recurrent angina; Trimetazidine

Indexed keywords

ANTIANGINA PECTORIS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; FATTY ACID; GLUCOSE; METOPROLOL; NITRIC ACID DERIVATIVE; PLACEBO; TRIMETAZIDINE;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; ATRIOVENTRICULAR BLOCK; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; ENERGY METABOLISM; FATTY ACID OXIDATION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPOTENSION; MORBIDITY; MORTALITY; ONSET AGE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SIDE EFFECT; SINUS BRADYCARDIA; ST SEGMENT DEPRESSION; TREADMILL EXERCISE; TREATMENT OUTCOME;

ANGINA PECTORIS; HUMANS; MYOCARDIAL REVASCULARIZATION; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 3042708829     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Serruys P, Unger F, Sousa JE, Jakene A, Bonnier HJ, Schonberger JP, et al. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344:1117-1124.
2. Hemingway H, Crook A, Feder G, Banerjee S, Dawson JR, Magee P, et al. Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med 2001; 344: 645-654.
3. Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 2000; 86:580-588.
4. Sellier P, Audouin P, Payen B, et al. Ergometric effects of a single administration of trimetazidine. Presse Med 1986; 15:1771-1774.
5. Passeron J. Effectiveness of trimetazidine in stable effort angina due to chronic coronary insufficiency: a double-blind versus placebo study. Presse Med 1986; 15:1775-1778.
6. Marchanda SC, Krishnaswami S. Combination treatment with trimetazidine and diltiazem in stable angina pectoris. Heart 1997; 78:353-357.
7. Michaelides AP, Spiropoulos K, Dimopoulos K, Athanasiades D, Toutouzas P. Antianginal efficacy of the combination of trimetazidine-propranolol compared with isosorbide dinitrate-propranolol in patients with stable angina. Clin Drug Invest 1997; 13:8-14.
8. Levy S. Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. Group of South of France Investigators. Am J Cardiol 1995; 76:12B-16B.
9. Lu C, Dabrowski P, Fragasso G, Chierchia SL. Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary disease. Am J Cardiol 1998; 82:898-901.
10. Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 1997; 18:394-413.
11. Szwed H, Sadowski Z, Elikowski W, Koronkiewicz A, Mamcarz A, Orszulak W, et al. Combination treatment in stable effort angina using trimetazidine and metoprolol. Results of a randomized, double-blind, multicentre study (TRIMPOL II). Eur Heart J 2000; 22:2267-2274.
12. Szwed H, Pachocki R, Domzal-Bochen̄ska M, Szymczak K, Szydlowski Z, Paradowski A, et al. The anti-anginal efficacy and tolerability of trimetazidine in patients with stable effort angina treated also with one of the conventional antianginal drugs. ESS 1997; 4:237-247.
13. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16:434-444.
14. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 242:2035-2038.
15. Henry P, Makowski S, Richard P, Beverelli F, Casanova S, Louali A, et al. Increased incidence of moderate stenosis among patients with diabetes. Substrate for myocardial infarction? Am Heart J 1997; 134:1037-1043.
16. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol 1989; 14:49-57.
17. Barrett El, Schwartz RG, Francis CK, Zaret BL. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog. J Clin Invest 1984; 74:1073-1079.
18. Gamble J, Lopaschuk GD. Glycolysis and glucose oxidation during reperfusion of ischemic heart from diabetic rats. Biochem Biophys Acta 1994; 1225:191-199.
19. Lopaschuk GD. Abnormal mechanical function in diabetes: relationship to altered myocardial carbohydrate/lipid metabolism. Coron Artery Dis 1996; 7:116-123.
20. Szwed H, Sadowski Z, Pachocki R, Domzal-Bochenska M, Szymczak K, Szydlowski Z, et al. The anti-ischemic effects and tolerability of trimetazidine in coronary diabetic patients. A substudy from TRIMPOL 1. Cardiovasc Drugs Ther 1999; 13:217-222.
21. Lytle BW, Loop FD, Taylor PC, Simpfendorfer C, Kramer JR, Ratliff NB, et al. Vein graft disease: the clinical impact of stenosis in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg 1992; 103:831-840.
22. Szwed H, Sadowski Z, Pachocki R, Domzal-Bochenska M, Malczewska B, Jedrzejczyk B, et al. Anti-Ischaemic Efficacy and Tolerability of trimetazidine in Elderly Patients with Angina Pectoris. A Sub-Study from TRIMPOL-1. (Trimetazidine in Poland). Clin Drug Invest 2000; 19:1-8.
23. Fox KM, Mulcahy D, Findlay I, Ford I, Dargie HJ. The TIBET Study Group. The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and total ischaemic burden in 608 patients with stable angina. Eur Heart J 1996; 17:96-103.
24. Savonitto S, Ardissino D, Egstrup K, Rasmussen K, Bae EA, Omland T, et al. on behalf of the IMAGE Study Group. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study. J Am Coll Cardiol 1996; 27:311-316.
25. Ferguson J, Ormerod O, Lenox-Smith A. Bisoprolol alone and in combination with amlodipine or nifedipine in the treatment of chronic stable angina. Int J Clin Practice 2000; 54:360-363.
26. Akras F, Jackson G. Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina. Lancet 1991; 338:1036-1039.
27. Pornin M, Harpey C, Allal J, Sellier P, Ourbak P. Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study. Clin Trials Metaanal 1994; 29:49-56.